Gilead Sciences
GILD
#81
Rank
A$300.31 B
Marketcap
A$242.12
Share price
-0.41%
Change (1 day)
33.17%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): -A$2.5 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are A$30.45 Billion. In 2025 the company made an earning of A$14.21 Billion, an increase over its 2024 earnings that were of A$1.00 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$2.5 Billion-117.55%
2025 A$14.21 B1319.86%
2024 A$1.00 B-89.94%
2023 A$9.95 B17.97%
2022 A$8.43 B-29.77%
2021 A$12.00 B395.99%
2020 A$2.42 B-67.66%
2019 A$7.48 B-33.84%
2018 A$11.31 B-42.35%
2017 A$19.62 B-20.87%
2016 A$24.80 B-21.06%
2015 A$31.42 B45.8%
2014 A$21.55 B253.01%
2013 A$6.10 B16.51%
2012 A$5.24 B-1.07%
2011 A$5.29 B-6.71%
2010 A$5.67 B11.75%
2009 A$5.08 B29.5%
2008 A$3.92 B19.11%
2007 A$3.29 B-455.74%
2006 -A$0.93 Billion-154.93%
2005 A$1.68 B76.99%
2004 A$0.95 B-266.16%
2003 -A$0.58 Billion-638.24%
2002 A$0.10 B31.5%
2001 A$80.97 M-242.15%
2000 -A$56.97 Million-40.2%
1999 -A$95.27 Million31.85%
1998 -A$72.25 Million8.73%
1997 -A$66.45 Million27.22%
1996 -A$52.23 Million
1994 -A$49.77 Million26.57%
1993 -A$39.32 Million46.49%
1992 -A$26.84 Million362.5%
1991 -A$5.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.16 B-1,057.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.02 B-453.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$12.62 B-544.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$50.44 B-1,878.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.92 B-626.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$1.46 B-151.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.68 B-159.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$7.31 B-358.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.15 B-493.35%๐Ÿ‡บ๐Ÿ‡ธ USA